DV
Dividend Vision

GLSI — Greenwich Lifesciences Inc

Greenwich Lifesciences Inc (GLSI)

Total return is 236.0% over the past 5.9 years, 80.6 points ahead of SPY at 155.4%. Its deepest 1-year drawdown was 61.9%.

GLSI appears to be a single-stock equity holding rather than a traditional diversified ETF, focused on Greenwich Lifesciences Inc. With no reported distribution rate, expense ratio, or assets under management available, the fund structure and income characteristics are unclear. This holding may appeal to investors with conviction in the underlying company's prospects, though the lack of diversification and limited available financial metrics suggest careful due diligence is warranted.

GLSI key facts

Asset type
Stock
Asset class
Equity
Inception date
09/25/2020
Last close
$16.80
Market cap
$239,548,352
Average volume
116500.0
Beta
1.393
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.61